Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Peptide YY"" wg kryterium: Temat


Tytuł :
Crystal structures of human neuropeptide Y (NPY) and peptide YY (PYY).
Autorzy :
Langley DB; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, New South Wales 2010, Australia.
Schofield P; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, New South Wales 2010, Australia.
Jackson J; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, New South Wales 2010, Australia.
Herzog H; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, New South Wales 2010, Australia; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, Australia.
Christ D; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, New South Wales 2010, Australia; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, Australia. Electronic address: .
Pokaż więcej
Źródło :
Neuropeptides [Neuropeptides] 2022 Apr; Vol. 92, pp. 102231. Date of Electronic Publication: 2022 Feb 07.
Typ publikacji :
Journal Article
MeSH Terms :
Neuropeptide Y*
Peptide YY*
Humans ; Pancreatic Polypeptide ; Receptors, Neuropeptide Y
Czasopismo naukowe
Tytuł :
Peptide-YY 3-36 /glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries.
Autorzy :
Boland BB; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Gubra ApS, Horsholm, Denmark; PRECISIONscientia, Yardley, PA, USA.
Laker RC; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
O'Brien S; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Sitaula S; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Sermadiras I; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Nielsen JC; Gubra ApS, Horsholm, Denmark.
Barkholt P; Gubra ApS, Horsholm, Denmark.
Roostalu U; Gubra ApS, Horsholm, Denmark.
Hecksher-Sørensen J; Gubra ApS, Horsholm, Denmark.
Sejthen SR; Gubra ApS, Horsholm, Denmark.
Thorbek DD; Gubra ApS, Horsholm, Denmark.
Suckow A; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; DTX Pharma, San Diego, CA, USA.
Burmeister N; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Roche, Penzberg, Germany.
Oldham S; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Will S; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Howard VG; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Gill BM; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Newton P; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Antibody and Protein Engineering, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Naylor J; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Hornigold DC; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Austin J; University of Chicago Advanced Electron Microscopy Core Facility, Chicago, IL, USA.
Lantier L; Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA.
McGuinness OP; Vanderbilt University Mouse Metabolic Phenotyping Center, Nashville, TN, USA.
Trevaskis JL; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Gilead Sciences, Foster City, CA, USA.
Grimsby JS; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Rhodes CJ; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Electronic address: .
Pokaż więcej
Źródło :
Molecular metabolism [Mol Metab] 2022 Jan; Vol. 55, pp. 101392. Date of Electronic Publication: 2021 Nov 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Glucagon-Like Peptide 1/*metabolism
Obesity/*metabolism
Peptide YY/*metabolism
Animals ; Blood Glucose/metabolism ; Body Weight/drug effects ; Diabetes Mellitus, Experimental/metabolism ; Diabetes Mellitus, Type 2/metabolism ; Diet ; Eating/drug effects ; Energy Intake/drug effects ; Energy Metabolism/drug effects ; Gastric Bypass ; Glucagon-Like Peptide-1 Receptor/metabolism ; Hypothalamus ; Insulin Resistance/physiology ; Insulin-Secreting Cells/metabolism ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Obese ; Obesity/physiopathology ; Peptide YY/physiology ; Weight Loss
Czasopismo naukowe
Tytuł :
Gastrointestinal peptides in eating-related disorders.
Autorzy :
Smith KR; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States. Electronic address: .
Moran TH; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, United States.
Pokaż więcej
Źródło :
Physiology & behavior [Physiol Behav] 2021 Sep 01; Vol. 238, pp. 113456. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Ghrelin*
Peptide YY*
Appetite ; Cholecystokinin ; Eating ; Glucagon-Like Peptide 1
Czasopismo naukowe
Tytuł :
Safety and efficacy of an extended-release peptide YY analogue for obesity: A randomized, placebo-controlled, phase 1 trial.
Autorzy :
Tan TM; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Zihipp Ltd, London, UK.
Minnion J; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Zihipp Ltd, London, UK.
Khoo B; Division of Medicine, University College London, London, UK.
Ball LJ; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.
Malviya R; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Zihipp Ltd, London, UK.
Day E; Imperial Clinical Trials Unit, Imperial College London, London, UK.
Fiorentino F; Imperial Clinical Trials Unit, Imperial College London, London, UK.; Department of Surgery and Cancer, Imperial College London, London, UK.
Brindley C; Kinetassist Ltd., Quothquan, UK.
Bush J; Covance Clinical Research Unit, Leeds, UK.
Bloom SR; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.; Zihipp Ltd, London, UK.
Pokaż więcej
Źródło :
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Jul; Vol. 23 (7), pp. 1471-1483. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Obesity*/drug therapy
Peptide YY*
Double-Blind Method ; Humans ; Overweight ; United Kingdom
Czasopismo naukowe
Tytuł :
Ninjin'yoeito modulates feeding and activity under negative energy balance conditions via the NPY system.
Autorzy :
Zhang L; Neuroscience Division, Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, Sydney, Australia; St. Vincent's Clinical School, University of NSW, Sydney, Australia. Electronic address: .
Clark T; The Charles Perkins Centre, School of Life & Environmental Sciences, The University of Sydney, NSW 2006, Australia.
Gopalasingam G; Neuroscience Division, Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, Sydney, Australia.
Neely GG; The Charles Perkins Centre, School of Life & Environmental Sciences, The University of Sydney, NSW 2006, Australia.
Herzog H; Neuroscience Division, Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, Sydney, Australia; School of Medical Sciences, University of NSW, Sydney, NSW, Australia; Faculty of Medicine, University of NSW, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Neuropeptides [Neuropeptides] 2021 Jun; Vol. 87, pp. 102149. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drugs, Chinese Herbal/*pharmacology
Energy Intake/*drug effects
Energy Metabolism/*drug effects
Feeding Behavior/*drug effects
Motor Activity/*drug effects
Neuropeptide Y/*metabolism
Peptide YY/*deficiency
Receptors, Neuropeptide Y/*deficiency
Animals ; Cross-Over Studies ; Drosophila melanogaster ; Female ; Homeostasis ; Humans ; Male ; Medicine, Kampo ; Metabolism/drug effects ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Peptide YY/genetics ; Peptide YY/physiology ; Random Allocation ; Receptors, Neuropeptide Y/genetics ; Receptors, Neuropeptide Y/physiology
Czasopismo naukowe
Tytuł :
Rational Development of Stable PYY 3-36 Peptide Y 2 Receptor Agonists.
Autorzy :
Poulsen C; Global Research Technology, Novo Nordisk A/S, Måløv, Denmark. .
Pedersen MØ; Global Research Technology, Novo Nordisk A/S, Måløv, Denmark.
Wahlund PO; Global Research Technology, Novo Nordisk A/S, Måløv, Denmark.
Sjölander A; Global Research Technology, Novo Nordisk A/S, Måløv, Denmark.
Thomsen JK; Hellerup, Denmark.
Conde-Frieboes KW; Global Research Technology, Novo Nordisk A/S, Måløv, Denmark.
Paulsson JF; Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.
Wulff BS; Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.
Østergaard S; Global Research Technology, Novo Nordisk A/S, Måløv, Denmark.
Pokaż więcej
Źródło :
Pharmaceutical research [Pharm Res] 2021 Aug; Vol. 38 (8), pp. 1369-1385. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Peptide Fragments/*chemistry
Peptide YY/*chemistry
Receptors, Neuropeptide Y/*agonists
Asparagine/chemistry ; Drug Development ; HEK293 Cells ; Humans ; Peptide Fragments/pharmacology ; Peptide YY/pharmacology
Czasopismo naukowe
Tytuł :
Single nucleotide polymorphism in CD36: Correlation to peptide YY levels in obese and non-obese adults.
Autorzy :
Karthi M; Molecular Physiology Laboratory, Department of Biochemistry, Bharathiar University, Coimbatore, Tamilnadu, 641046, India.
Deepankumar S; Molecular Physiology Laboratory, Department of Biochemistry, Bharathiar University, Coimbatore, Tamilnadu, 641046, India.
Vinithra P; Molecular Physiology Laboratory, Department of Biochemistry, Bharathiar University, Coimbatore, Tamilnadu, 641046, India.
Gowtham S; Molecular Physiology Laboratory, Department of Biochemistry, Bharathiar University, Coimbatore, Tamilnadu, 641046, India.
Vasanth K; Molecular Biology Laboratory, Department of Botany, Bharathiar University, Coimbatore, Tamilnadu, 641046, India.
Praveen Raj P; Department of Bariatric Surgery, GEM Hospital and Research Centre, Coimbatore, Tamilnadu, 641045, India.
Senthilkumar R; Department of Diabetes and Endocrinology, PSG Hospitals, Coimbatore, Tamilnadu, 641004, India.
Selvakumar S; Molecular Physiology Laboratory, Department of Biochemistry, Bharathiar University, Coimbatore, Tamilnadu, 641046, India. Electronic address: .
Pokaż więcej
Źródło :
Clinical nutrition (Edinburgh, Scotland) [Clin Nutr] 2021 May; Vol. 40 (5), pp. 2707-2715. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Polymorphism, Single Nucleotide*
CD36 Antigens/*genetics
Obesity/*metabolism
Peptide YY/*blood
Gene Expression Regulation ; Genetic Variation ; Humans ; Obesity/blood ; Obesity/genetics ; Peptide YY/genetics ; Peptide YY/metabolism
Czasopismo naukowe
Tytuł :
An extract of hops (Humulus lupulus L.) modulates gut peptide hormone secretion and reduces energy intake in healthy-weight men: a randomized, crossover clinical trial.
Autorzy :
Walker EG; The New Zealand Institute for Plant and Food Research Limited, Auckland, New Zealand.
Lo KR; The New Zealand Institute for Plant and Food Research Limited, Auckland, New Zealand.
Pahl MC; The New Zealand Institute for Plant and Food Research Limited, Auckland, New Zealand.
Shin HS; Human Nutrition Unit; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
Lang C; The New Zealand Institute for Plant and Food Research Limited, Auckland, New Zealand.
Wohlers MW; The New Zealand Institute for Plant and Food Research Limited, Auckland, New Zealand.
Poppitt SD; Human Nutrition Unit; School of Biological Sciences, University of Auckland, Auckland, New Zealand.
Sutton KH; The New Zealand Institute for Plant and Food Research Limited, Lincoln, New Zealand.
Ingram JR; The New Zealand Institute for Plant and Food Research Limited, Auckland, New Zealand.
Pokaż więcej
Źródło :
The American journal of clinical nutrition [Am J Clin Nutr] 2022 Mar 04; Vol. 115 (3), pp. 925-940.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Humulus*
Blood Glucose ; Capsules/pharmacology ; Cross-Over Studies ; Energy Intake/physiology ; Gastrointestinal Agents/pharmacology ; Humans ; Insulin ; Male ; Peptide YY ; Plant Extracts/pharmacology
Czasopismo naukowe
Tytuł :
The Design of a GLP-1/PYY Dual Acting Agonist.
Autorzy :
Østergaard S; Global Research Technologies, Novo Nordisk Research Park, 2760, Maaloev, Denmark.
Paulsson JF; Global Drug Discovery, Novo Nordisk Research Park, 2760, Maaloev, Denmark.
Kjaergaard Gerstenberg M; Global Drug Discovery, Novo Nordisk Research Park, 2760, Maaloev, Denmark.
Wulff BS; Global Drug Discovery, Novo Nordisk Research Park, 2760, Maaloev, Denmark.
Pokaż więcej
Źródło :
Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2021 Apr 06; Vol. 60 (15), pp. 8268-8275. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Design*
Glucagon-Like Peptide 1/*pharmacology
Glucagon-Like Peptide-1 Receptor/*agonists
Peptide Fragments/*pharmacology
Peptide YY/*pharmacology
Receptors, Gastrointestinal Hormone/*agonists
Crystallography, X-Ray ; Glucagon-Like Peptide 1/chemical synthesis ; Glucagon-Like Peptide 1/chemistry ; Humans ; Models, Molecular ; Peptide Fragments/chemical synthesis ; Peptide Fragments/chemistry ; Peptide YY/chemical synthesis ; Peptide YY/chemistry
Czasopismo naukowe
Tytuł :
The Role of D-allulose and Erythritol on the Activity of the Gut Sweet Taste Receptor and Gastrointestinal Satiation Hormone Release in Humans: A Randomized, Controlled Trial.
Autorzy :
Teysseire F; St. Clara Research Ltd at St. Claraspital, Basel, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Bordier V; St. Clara Research Ltd at St. Claraspital, Basel, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Budzinska A; Laboratory for Brain-Gut Axis Studies, Translational Research Center for Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.
Weltens N; Laboratory for Brain-Gut Axis Studies, Translational Research Center for Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.
Rehfeld JF; Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Holst JJ; Department of Biomedical Sciences and Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Hartmann B; Department of Biomedical Sciences and Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Beglinger C; St. Clara Research Ltd at St. Claraspital, Basel, Switzerland.
Van Oudenhove L; Laboratory for Brain-Gut Axis Studies, Translational Research Center for Gastrointestinal Disorders, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.; Leuven Brain Institute, KU Leuven, Leuven, Belgium.; Cognitive and Affective Neuroscience Lab, Department of Psychological and Brain Sciences, Dartmouth College, Hanover, NH, USA.
Wölnerhanssen BK; St. Clara Research Ltd at St. Claraspital, Basel, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Meyer-Gerspach AC; St. Clara Research Ltd at St. Claraspital, Basel, Switzerland.; Faculty of Medicine, University of Basel, Basel, Switzerland.
Pokaż więcej
Źródło :
The Journal of nutrition [J Nutr] 2022 May 05; Vol. 152 (5), pp. 1228-1238.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Gastrointestinal Hormones*
Cholecystokinin ; Cross-Over Studies ; Erythritol ; Female ; Fructose ; Glucagon-Like Peptide 1 ; Humans ; Male ; Peptide YY ; Satiation ; Taste ; Tyrosine ; Water
Czasopismo naukowe
Tytuł :
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus.
Autorzy :
Qi L; Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Wei Q; Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China; Institute of Pancreas, Southeast University, Nanjing, China.
Ni M; Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210009, China.
Liu D; Institute of Pancreas, Southeast University, Nanjing, China; Department of Clinical Science and Research, Zhongda Hospital, Southeast University, Nanjing, China.
Bao J; Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Lv Y; Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
Xia H; Department of Endocrinology, Jintan District People's Hospital Affiliated to Jiangsu University, Changzhou, China.
Wang Q; Department of Endocrinology, Jintan District People's Hospital Affiliated to Jiangsu University, Changzhou, China.
Wang L; Department of Gastroenterology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210009, China. Electronic address: .
Su J; Jintan District People's Hospital Affiliated to Jiangsu University, Changzhou 213200, China. Electronic address: .
Sj P; Division of Gastroenterology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States. Electronic address: .
Li L; Department of Endocrinology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China; Institute of Pancreas, Southeast University, Nanjing, China. Electronic address: .
Pokaż więcej
Źródło :
Diabetes & metabolism [Diabetes Metab] 2022 May; Vol. 48 (3), pp. 101316. Date of Electronic Publication: 2021 Dec 17.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Insulin Resistance*
Pancreatitis, Chronic*
Blood Glucose ; C-Peptide ; Gastric Inhibitory Polypeptide ; Ghrelin ; Glucagon ; Glucagon-Like Peptide 1 ; Humans ; Insulin ; Peptide YY
Czasopismo naukowe
Tytuł :
Gastric Mobility and Gastrointestinal Hormones in Older Patients with Sarcopenia.
Autorzy :
Huang HH; Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei 112201, Taiwan.; Institute of Emergency and Critical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
Wang TY; Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei 112201, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
Yao SF; Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei 112201, Taiwan.
Lin PY; Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei 112201, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
Chang JC; Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei 112201, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
Peng LN; Aging and Health Research Center, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei 112201, Taiwan.
Chen LK; Aging and Health Research Center, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, Taipei 112201, Taiwan.; Taipei Municipal Gan-Dau Hospital, Taipei 112020, Taiwan.
Yen DH; Department of Emergency Medicine, Taipei Veterans General Hospital, Taipei 112201, Taiwan.; Institute of Emergency and Critical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.; Department of Emergency Medicine, National Defense Medical Center, Taipei 114202, Taiwan.; Department of Nursing, Yuanpei University of Medical Technology, Hsinchu 300102, Taiwan.
Pokaż więcej
Źródło :
Nutrients [Nutrients] 2022 Apr 30; Vol. 14 (9). Date of Electronic Publication: 2022 Apr 30.
Typ publikacji :
Journal Article
MeSH Terms :
Gastrointestinal Hormones*
Sarcopenia*
Aged ; Aged, 80 and over ; Cholecystokinin ; Gastric Emptying ; Ghrelin ; Glucagon-Like Peptide 1 ; Humans ; Peptide YY ; Prospective Studies
Czasopismo naukowe
Tytuł :
Peptide YY 3-36 attenuates trinitrobenzene sulfonic acid-induced colitis in mice by modulating Th1/Th2 differentiation.
Autorzy :
Li Z; Department of Immunology, College of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, China.; Provincial Key Laboratory of Modern Pathogen Biology, College of Basic Medicine, Guizhou Medical University, Department of Medical Parasitology, College of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
Kuang X; Department of Immunology, College of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
Chen T; Graduate School, Zunyi Medical University, Zunyi, Guizhou, China.
Shen T; Department of Immunology, College of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
Wu J; Provincial Key Laboratory of Modern Pathogen Biology, College of Basic Medicine, Guizhou Medical University, Department of Medical Parasitology, College of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2022 Apr; Vol. 13 (4), pp. 10144-10158.
Typ publikacji :
Journal Article
MeSH Terms :
Colitis*/chemically induced
Colitis*/pathology
Crohn Disease*/chemically induced
Animals ; Cytokines/metabolism ; Disease Models, Animal ; Interleukin-6 ; Mice ; Mice, Inbred BALB C ; Peptide YY/adverse effects ; Trinitrobenzenesulfonic Acid/toxicity ; Tumor Necrosis Factor-alpha/genetics
Czasopismo naukowe
Tytuł :
Differences in gastrointestinal hormones and appetite ratings among obesity classes.
Autorzy :
Aukan MI; Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, 7491, Trondheim, Norway. Electronic address: .
Nymo S; Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, 7491, Trondheim, Norway; Nord-Trøndelag Hospital Trust, Clinic of Surgery, Namsos Hospital, Norway; Centre of Obesity and Innovation ObeCe, Clinic of Surgery, St. Olav University Hospital, 7006, Trondheim, Norway.
Haagensli Ollestad K; Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, 7491, Trondheim, Norway.
Akersveen Boyesen G; Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, 7491, Trondheim, Norway.
DeBenedictis JN; Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, 7491, Trondheim, Norway.
Rehfeld JF; Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, 2100, Copenhagen, Denmark.
Coutinho S; Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, 7491, Trondheim, Norway.
Martins C; Obesity Research Group, Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology NTNU, 7491, Trondheim, Norway; Centre of Obesity and Innovation ObeCe, Clinic of Surgery, St. Olav University Hospital, 7006, Trondheim, Norway; Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, USA.
Pokaż więcej
Źródło :
Appetite [Appetite] 2022 Apr 01; Vol. 171, pp. 105940. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Appetite*
Gastrointestinal Hormones*
Adult ; Cholecystokinin ; Cross-Sectional Studies ; Ghrelin ; Glucagon-Like Peptide 1 ; Humans ; Insulin ; Obesity ; Peptide YY ; Postprandial Period/physiology
Czasopismo naukowe
Tytuł :
Impact on Glucose Homeostasis: Is Food Biofortified with Molybdenum a Workable Solution? A Two-Arm Study.
Autorzy :
Vasto S; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, 90128 Palermo, Italy.; Euro-Mediterranean Institutes of Science and Technology (IEMEST), 90139 Palermo, Italy.
Di Gaudio F; Department of Promoting Health, Maternal-Infant, Excellence and Internal and Specialized Medicine (ProMISE) G. D'Alessandro, University of Palermo, 90127 Palermo, Italy.
Raso M; Chromatography and Mass Spectrometry Section, Quality Control and Chemical Risk (CQRC), Department PROMISE, University Palermo, 90133 Palermo, Italy.
Sabatino L; Dipartimento Scienze Agrarie, Alimentari e Forestali (SAAF), University of Palermo, Viale delle Scienze, Ed. 5, 90128 Palermo, Italy.
Caldarella R; Department of Laboratory Medicine, 'P. Giaccone' University Hospital, 90128 Palermo, Italy.
De Pasquale C; Dipartimento Scienze Agrarie, Alimentari e Forestali (SAAF), University of Palermo, Viale delle Scienze, Ed. 5, 90128 Palermo, Italy.
Di Rosa L; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, 90128 Palermo, Italy.
Baldassano S; Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Viale delle Scienze, 90128 Palermo, Italy.
Pokaż więcej
Źródło :
Nutrients [Nutrients] 2022 Mar 24; Vol. 14 (7). Date of Electronic Publication: 2022 Mar 24.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2*
Food, Fortified*
Insulin Resistance*
Molybdenum*/administration & dosage
Blood Glucose ; Gastric Inhibitory Polypeptide ; Glucagon-Like Peptide 1 ; Glucagon-Like Peptide 2 ; Glucose ; Homeostasis ; Humans ; Insulin ; Lettuce ; Peptide YY
Czasopismo naukowe
Tytuł :
Lack of peptide YY signaling in mice disturbs gut microbiome composition in response to high-fat diet.
Autorzy :
Farzi A; Neuroscience Division, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, NSW, Australia.; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Ip CK; Neuroscience Division, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, NSW, Australia.; Faculty of Medicine, University of NSW, Sydney, NSW, Australia.
Reed F; Neuroscience Division, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, NSW, Australia.
Enriquez R; Neuroscience Division, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, NSW, Australia.
Zenz G; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Durdevic M; Center for Medical Research, Medical University of Graz, Graz, Austria.; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.; Theodor Escherich Laboratory for Medical Microbiome Research, Medical University of Graz, Graz, Austria.
Zhang L; Neuroscience Division, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, NSW, Australia.; Faculty of Medicine, University of NSW, Sydney, NSW, Australia.
Holzer P; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
Herzog H; Neuroscience Division, Garvan Institute of Medical Research, St. Vincent's Hospital, Darlinghurst, NSW, Australia.; Faculty of Medicine, University of NSW, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2021 Apr; Vol. 35 (4), pp. e21435.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gastrointestinal Microbiome*
Bacteria/*classification
Diet, High-Fat/*adverse effects
Peptide YY/*metabolism
Animals ; Body Composition ; Mice ; Mice, Knockout ; Peptide YY/genetics
Czasopismo naukowe
Tytuł :
Neuroendocrine Peptides of the Gut and Their Role in the Regulation of Food Intake.
Autorzy :
Schalla MA; Charité Center for Internal Medicine and Dermatology, Department for Psychosomatic Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
Taché Y; Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, CURE: Digestive Diseases Research Center, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.; VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
Stengel A; Charité Center for Internal Medicine and Dermatology, Department for Psychosomatic Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.; Department of Psychosomatic Medicine and Psychotherapy, Medical University Hospital Tübingen, Tübingen, Germany.
Pokaż więcej
Źródło :
Comprehensive Physiology [Compr Physiol] 2021 Apr 01; Vol. 11 (2), pp. 1679-1730. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Cholecystokinin*
Peptide YY*
Eating ; Glucagon-Like Peptide 1 ; Oxyntomodulin
Czasopismo naukowe
Tytuł :
Appetite responses to pecan-enriched diets.
Autorzy :
Guarneiri LL; Department of Nutritional Sciences, University of Georgia, Athens, GA, USA.
Paton CM; Department of Nutritional Sciences, University of Georgia, Athens, GA, USA; Department of Food Science and Technology, University of Georgia, Athens, GA, USA.
Cooper JA; Department of Nutritional Sciences, University of Georgia, Athens, GA, USA. Electronic address: .
Pokaż więcej
Źródło :
Appetite [Appetite] 2022 Jun 01; Vol. 173, pp. 106003. Date of Electronic Publication: 2022 Mar 17.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Carya*
Adult ; Appetite ; Cross-Over Studies ; Diet ; Energy Intake ; Ghrelin ; Humans ; Peptide YY ; Postprandial Period ; Prospective Studies
Czasopismo naukowe
Tytuł :
Bioimaging and Biodistribution of the Metal-Ion-Controlled Self-Assembly of PYY 3-36 Studied by SPECT/CT.
Autorzy :
Kalomoiri P; Center for Biopharmaceuticals and Biobarriers in Drug Delivery, Department of Chemistry, University of Copenhagen, Thorvaldsensvej 40, 1871, Frederiksberg, Denmark.
Rodríguez-Rodríguez C; Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.; Department of Physics and Astronomy, University of British Columbia, 6224 Agricultural Road, Vancouver, British Columbia, V6T 1Z1, Canada.
Sørensen KK; Center for Biopharmaceuticals and Biobarriers in Drug Delivery, Department of Chemistry, University of Copenhagen, Thorvaldsensvej 40, 1871, Frederiksberg, Denmark.
Bergamo M; Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.
Saatchi K; Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.
Häfeli UO; Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.; Center for Drug Delivery and Biophysics of Biopharmaceuticals, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100, Copenhagen, Denmark.
Jensen KJ; Center for Biopharmaceuticals and Biobarriers in Drug Delivery, Department of Chemistry, University of Copenhagen, Thorvaldsensvej 40, 1871, Frederiksberg, Denmark.
Pokaż więcej
Źródło :
Chembiochem : a European journal of chemical biology [Chembiochem] 2020 Dec 01; Vol. 21 (23), pp. 3338-3348. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Tomography, Emission-Computed, Single-Photon*
Tomography, X-Ray Computed*
Copper/*pharmacokinetics
Peptide YY/*pharmacokinetics
2,2'-Dipyridyl/chemistry ; 2,2'-Dipyridyl/pharmacokinetics ; Animals ; Coordination Complexes/chemical synthesis ; Coordination Complexes/chemistry ; Coordination Complexes/pharmacokinetics ; Copper/chemistry ; Female ; Kidney Cortex/chemistry ; Kidney Cortex/metabolism ; Ligands ; Mice ; Mice, Inbred C57BL ; Peptide YY/chemical synthesis ; Peptide YY/chemistry ; Renal Elimination ; Tissue Distribution
Czasopismo naukowe
Tytuł :
Peptide YY 3-36 concentration in acute- and long-term recovered anorexia nervosa.
Autorzy :
Tam FI; Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.; Department of Child and Adolescent Psychiatry, Faculty of Medicine, Eating Disorder Treatment and Research Center, Technische Universität Dresden, Dresden, Germany.
Seidel M; Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.; Department of Child and Adolescent Psychiatry, Faculty of Medicine, Eating Disorder Treatment and Research Center, Technische Universität Dresden, Dresden, Germany.
Boehm I; Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.; Department of Child and Adolescent Psychiatry, Faculty of Medicine, Eating Disorder Treatment and Research Center, Technische Universität Dresden, Dresden, Germany.
Ritschel F; Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Bahnsen K; Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Biemann R; Institute for Clinical Chemistry and Pathobiochemistry, Otto-Von-Guericke University Magdeburg, Magdeburg, Germany.
Weidner K; Department of Psychotherapy and Psychosomatic Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Roessner V; Department of Child and Adolescent Psychiatry, Faculty of Medicine, University Hospital C. G. Carus, Technische Universität Dresden, Dresden, Germany.
Ehrlich S; Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, Technische Universität Dresden, Fetscherstraße 74, 01307, Dresden, Germany. .; Department of Child and Adolescent Psychiatry, Faculty of Medicine, Eating Disorder Treatment and Research Center, Technische Universität Dresden, Dresden, Germany. .
Pokaż więcej
Źródło :
European journal of nutrition [Eur J Nutr] 2020 Dec; Vol. 59 (8), pp. 3791-3799. Date of Electronic Publication: 2020 Mar 12.
Typ publikacji :
Journal Article
MeSH Terms :
Anorexia Nervosa*
Peptide YY*
Appetite ; Body Mass Index ; Cross-Sectional Studies ; Humans ; Thinness
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies